Helsingborg Hospital, a part of the Region Skane SUND is the main trial sponsor.
Vetenskapsrådet - The Swedish Research Council
Main funding organisation. The TTM-2 trial is supported by a clinical research environment grant. Grant Nr: 2016-00428
The Swedish Research Council is a public agency under the authority of the Ministry of Education and Research. The Swedish Research Council has a leading role in developing Swedish research of the highest scientific quality, thereby contributing to the development of society.
Gorthon Stiftelsen - The Gorthon Foundation
The TTM2-trial is supported by an independent research grant from The Gorthon foundation, which supports medical research and training in Helsingborg, Sweden.
The TTM2 Trial is supported by an independent research grant from the Knutsson Foundation
Hans-Gabriel and Alice Trolle-Wachtmeister Foundation
The TTM2-trial is supported by an independent research grant from the Hans-Gabriel and Alice Trolle-Wachtmeister Foundation for Medical Research
Collaborating RCT. Investigating the effect of mild hypercapnia following out-of-hospital cardiac arrest.
ANZ Clinical Trials Registry Number: ACTRN12617000036314p
Copenhagen Trial Unit
Trial methodology development
Clinical Studies Sweden
Clinical Studies Sweden is a collaboration between the Swedish Research Council and Sweden's Health Care regions. In addition to the six regional nodes, the system consists of the Committee for Clinical Studies and the Office for Clinical Studies at the Swedish Research Council.